Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Maeurer

Showing results (61-70 of 206) with videos related to

Pageof 21
Sort By:
Transplantation|May 9, 2015
Allogeneic Hematopoietic Cell Transplantation for GATA2 Deficiency in a Patient With Disseminated Human Papillomavirus DiseaseMarkus Maeurer, Isabelle Magalhaes, Jan Andersson, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 27, 2015
Frequency of Mycobacterium tuberculosis-specific CD8+ T-cells in the course of anti-tuberculosis treatmentRebecca Axelsson-Robertson, Martin Rao, Andre G Loxton, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2015
B in TB: B Cells as Mediators of Clinically Relevant Immune Responses in TuberculosisMartin Rao, Davide Valentini, Thomas Poiret, et al.
Clinical Microbiology Reviews|October 6, 2021
Mesenchymal Stromal Cells: an Antimicrobial and Host-Directed Therapy for Complex Infectious DiseasesTimothy D Shaw, Anna D Krasnodembskaya, Gunnar N Schroeder, et al.
The Lancet. Microbe|September 5, 2025
Protecting the future of vaccine development amidst US funding withdrawal for mRNA vaccine researchEskild Petersen, Giuseppe Ippolito, Markus Maeurer, et al.
The Journal of Infectious Diseases|March 27, 2012
Eliminating tuberculosis and tuberculosis-HIV co-disease in the 21st century: key perspectives, controversies, unresolved issues, and needsAlimuddin Zumla, Rifat Atun, Markus Maeurer, et al.
Immunology|February 3, 2015
H1N1 viral proteome peptide microarray predicts individuals at risk for H1N1 infection and segregates infection versus Pandemrix(®) vaccinationAditya Ambati, Davide Valentini, Emanuele Montomoli, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 27, 2015
Cellular therapy in tuberculosisShreemanta K Parida, Rajhmun Madansein, Nalini Singh, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 1, 2021
Bacille Calmette-Guérin (BCG) vaccine and potential cross-protection against SARS-CoV-2 infection - Assumptions, knowns, unknowns and need for developing an accurate scientific evidence baseJean B Nachega, Markus Maeurer, Nadia A Sam-Agudu, et al.
Tropical Medicine & International Health : TM & IH|April 15, 2011
Achieving STOP TB Partnership goals: perspectives on development of new diagnostics, drugs and vaccines for tuberculosisPeter Mwaba, Ruth McNerney, Martin Peter Grobusch, et al.
Pageof 21

Showing results (61-70 of 206) with videos related to

Sort By:
Pageof 21
Transplantation|May 9, 2015
Allogeneic Hematopoietic Cell Transplantation for GATA2 Deficiency in a Patient With Disseminated Human Papillomavirus DiseaseMarkus Maeurer, Isabelle Magalhaes, Jan Andersson, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 27, 2015
Frequency of Mycobacterium tuberculosis-specific CD8+ T-cells in the course of anti-tuberculosis treatmentRebecca Axelsson-Robertson, Martin Rao, Andre G Loxton, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2015
B in TB: B Cells as Mediators of Clinically Relevant Immune Responses in TuberculosisMartin Rao, Davide Valentini, Thomas Poiret, et al.
Clinical Microbiology Reviews|October 6, 2021
Mesenchymal Stromal Cells: an Antimicrobial and Host-Directed Therapy for Complex Infectious DiseasesTimothy D Shaw, Anna D Krasnodembskaya, Gunnar N Schroeder, et al.
The Lancet. Microbe|September 5, 2025
Protecting the future of vaccine development amidst US funding withdrawal for mRNA vaccine researchEskild Petersen, Giuseppe Ippolito, Markus Maeurer, et al.
The Journal of Infectious Diseases|March 27, 2012
Eliminating tuberculosis and tuberculosis-HIV co-disease in the 21st century: key perspectives, controversies, unresolved issues, and needsAlimuddin Zumla, Rifat Atun, Markus Maeurer, et al.
Immunology|February 3, 2015
H1N1 viral proteome peptide microarray predicts individuals at risk for H1N1 infection and segregates infection versus Pandemrix(®) vaccinationAditya Ambati, Davide Valentini, Emanuele Montomoli, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 27, 2015
Cellular therapy in tuberculosisShreemanta K Parida, Rajhmun Madansein, Nalini Singh, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 1, 2021
Bacille Calmette-Guérin (BCG) vaccine and potential cross-protection against SARS-CoV-2 infection - Assumptions, knowns, unknowns and need for developing an accurate scientific evidence baseJean B Nachega, Markus Maeurer, Nadia A Sam-Agudu, et al.
Tropical Medicine & International Health : TM & IH|April 15, 2011
Achieving STOP TB Partnership goals: perspectives on development of new diagnostics, drugs and vaccines for tuberculosisPeter Mwaba, Ruth McNerney, Martin Peter Grobusch, et al.
Pageof 21